Clicky

Centogene N.V.(CNTG)

Description: Centogene BV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.


Keywords: Pharmaceutical Rare Diseases Recruitment Biomarkers Pharmaceutical Partners Diagnostics Services Christoph Ehlers

Home Page: www.centogene.com

CNTG Technical Analysis

Am Strande 7
Rostock, 18055
Germany
Phone: 49 381 80113 500


Officers

Name Title
Dr. Andrin Oswald M.D., Ph.D. Advisor
Ms. Kim Stratton CEO & Member of Management Board
Mr. Jose Miguel Coego Rios Chief Financial Officer
Dr. Patrice P. Denefle Ph.D. Chief Scientific Officer
Mr. Florian Vogel Ph.D. Chief Process Officer
Dr. Peter Bauer M.D. Chief Medical & Genomic Officer
Ms. Bettina Goerner Chief Data Officer
Mr. Lennart M. Streibel Director of Corp. Projects

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

GIC Sector: Health Care
GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
GIC Industry: Biotechnology
GIC Sub-Industry:
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.5904
Price-to-Sales TTM: 0.1281
IPO Date: 2019-11-07
Fiscal Year End: December
Full Time Employees: 808
Back to stocks